Novartis backs $30M round for cancer biotech; Bayer drug makes a 'breakthrough' at FDA - Endpoints News

Novartis backs $30M round for cancer biotech; Bayer drug makes a 'breakthrough' at FDA  Endpoints News

Ayala Therapeutics — which focuses on rare cancers that occur due to dysregulation of the Notch-​activating pathway — has raised $30 million in a round of ...